SIMCERE PHARMACEUTICAL GROUP Income Tax Expense
SIMCERE PHARMACEUTICAL GROUP reported Income Tax Expense of -CNY 5.58 million for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2013-04-26
CNY
| Period end | Income Tax Expense (Benefit) 12 month |
|---|---|
| 2012-12-31 | -5.58M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | -35.37M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | 10.64M CNY 20-F · filed 2013-04-26 |
| 2009-12-31 | 16.90M CNY 20-F · filed 2012-04-25 |
USD
| Period end | Income Tax Expense (Benefit) 12 month |
|---|---|
| 2012-12-31 | -$896.00K 20-F · filed 2013-04-26 |